Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma

H. Paripati; A. K. Stewart; S. Cabou; A. Dueck; V. J. Zepeda; N. Pirooz; C. Ehlenbeck; C. Reeder; J. Slack; J. F. Leis; J. Boesiger; A. S. Torloni; R. Fonseca; P. L. Bergsagel

doi:10.1038/sj.leu.2405100

Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma

H. Paripati, A. K. Stewart, S. Cabou, A. Dueck, V. J. Zepeda, N. Pirooz, C. Ehlenbeck, C. Reeder, J. Slack, J. F. Leis, J. Boesiger, A. S. Torloni, R. Fonseca, P. L. Bergsagel

Research output: Contribution to journal › Article › peer-review

113 Scopus citations

Original language	English (US)
Pages (from-to)	1282-1284
Number of pages	3
Journal	Leukemia
Volume	22
Issue number	6
DOIs	https://doi.org/10.1038/sj.leu.2405100
State	Published - Jun 2008

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/sj.leu.2405100

Cite this

@article{1348fdcc237243a294a56714bb0bc544,

title = "Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma",

author = "H. Paripati and Stewart, {A. K.} and S. Cabou and A. Dueck and Zepeda, {V. J.} and N. Pirooz and C. Ehlenbeck and C. Reeder and J. Slack and Leis, {J. F.} and J. Boesiger and Torloni, {A. S.} and R. Fonseca and Bergsagel, {P. L.}",

note = "Funding Information: We performed a retrospective chart review after the clinical observation of difficulty in mobilizing stem cells in patients treated with lenalidomide and dexamethasone was made. MM patients undergoing stem cell collection between January 2005 and October 2007 were analyzed for type and duration of induction therapy, collection efficacy and engraftment in patients who went to transplant. All data were extracted from patient medical records and from our transplant database. The study was approved by the Mayo Foundation Institutional Review Board.",

year = "2008",

month = jun,

doi = "10.1038/sj.leu.2405100",

language = "English (US)",

volume = "22",

pages = "1282--1284",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "6",

}

TY - JOUR

T1 - Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma

AU - Paripati, H.

AU - Stewart, A. K.

AU - Cabou, S.

AU - Dueck, A.

AU - Zepeda, V. J.

AU - Pirooz, N.

AU - Ehlenbeck, C.

AU - Reeder, C.

AU - Slack, J.

AU - Leis, J. F.

AU - Boesiger, J.

AU - Torloni, A. S.

AU - Fonseca, R.

AU - Bergsagel, P. L.

N1 - Funding Information: We performed a retrospective chart review after the clinical observation of difficulty in mobilizing stem cells in patients treated with lenalidomide and dexamethasone was made. MM patients undergoing stem cell collection between January 2005 and October 2007 were analyzed for type and duration of induction therapy, collection efficacy and engraftment in patients who went to transplant. All data were extracted from patient medical records and from our transplant database. The study was approved by the Mayo Foundation Institutional Review Board.

PY - 2008/6

Y1 - 2008/6

UR - http://www.scopus.com/inward/record.url?scp=44649143334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44649143334&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2405100

DO - 10.1038/sj.leu.2405100

M3 - Article

C2 - 18216870

AN - SCOPUS:44649143334

SN - 0887-6924

VL - 22

SP - 1282

EP - 1284

JO - Leukemia

JF - Leukemia

IS - 6

ER -

Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this